Search research articles
Contact Us
Filters
Showing results (371-380 of 442) with videos related to
Page
of 45
Sort By:
American Journal of Ophthalmology
|
June 8, 2025
Evidence and Consensus-Based Imaging Guidelines in Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE) - Multimodal imaging in Uveitis (MUV) Taskforce Report 7
Ester Carreño, Panayiotis Maghsoudlou, Alejandro Fonollosa, et al.
Progress in Retinal and Eye Research
|
January 14, 2020
Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index
Rupesh Agrawal, Jianbin Ding, Parveen Sen, et al.
Tuberculosis (Edinburgh, Scotland)
|
December 28, 2020
Proteomic profile of vitreous in patients with tubercular uveitis
Reema Bansal, Mohd M Khan, Surendra Dasari, et al.
Theranostics
|
May 8, 2023
Diagnosis and biomarkers for ocular tuberculosis: From the present into the future
Zhang Ludi, Ashita Ashish Sule, Ramar Perumal Samy, et al.
Ocular Immunology and Inflammation
|
June 6, 2024
Beyond Pathology- Exploring Salutogenesis as a Novel Approach to Eye Inflammatory Disease Prevention and Management: A Perspective
Collin Tan Yip Ming, William Rojas-Carabali, Carlos Cifuentes-González, et al.
American Journal of Ophthalmology
|
August 3, 2025
Minimum Imaging Sets for Diagnosis, Activity Assessment, and Complications in Noninfectious Posterior Uveitis - Multimodal Imaging in Uveitis (MUV) Task Force Report 9
Alessandro Invernizzi, Aniruddha Agarwal, Sapna Gangaputra, et al.
International Journal of Retina and Vitreous
|
March 25, 2021
Safety and efficacy of Razumab™ (world's first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study
Shashikant Sharma, Vishali Gupta, Aniruddha Maiti, et al.
Expert Opinion on Biological Therapy
|
May 8, 2026
Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III insight randomized clinical trial
Susan B Bressler, Piotr Oleksy, Daniel Virgil Alfaro, et al.
Ocular Immunology and Inflammation
|
September 18, 2023
Evaluating the Diagnostic Accuracy and Management Recommendations of ChatGPT in Uveitis
William Rojas-Carabali, Carlos Cifuentes-González, Xin Wei, et al.
Ocular Immunology and Inflammation
|
December 22, 2023
Response to the Comment on "Evaluating the Diagnostic Accuracy and Management Recommendations of ChatGpt in Uveitis"
William Rojas-Carabali, Carlos Cifuentes-González, Xin Wei, et al.
Page
of 45
Search research articles
Search
Showing results (371-380 of 442) with videos related to
Sort By:
Page
of 45
American Journal of Ophthalmology
|
June 8, 2025
Evidence and Consensus-Based Imaging Guidelines in Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE) - Multimodal imaging in Uveitis (MUV) Taskforce Report 7
Ester Carreño, Panayiotis Maghsoudlou, Alejandro Fonollosa, et al.
Progress in Retinal and Eye Research
|
January 14, 2020
Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index
Rupesh Agrawal, Jianbin Ding, Parveen Sen, et al.
Tuberculosis (Edinburgh, Scotland)
|
December 28, 2020
Proteomic profile of vitreous in patients with tubercular uveitis
Reema Bansal, Mohd M Khan, Surendra Dasari, et al.
Theranostics
|
May 8, 2023
Diagnosis and biomarkers for ocular tuberculosis: From the present into the future
Zhang Ludi, Ashita Ashish Sule, Ramar Perumal Samy, et al.
Ocular Immunology and Inflammation
|
June 6, 2024
Beyond Pathology- Exploring Salutogenesis as a Novel Approach to Eye Inflammatory Disease Prevention and Management: A Perspective
Collin Tan Yip Ming, William Rojas-Carabali, Carlos Cifuentes-González, et al.
American Journal of Ophthalmology
|
August 3, 2025
Minimum Imaging Sets for Diagnosis, Activity Assessment, and Complications in Noninfectious Posterior Uveitis - Multimodal Imaging in Uveitis (MUV) Task Force Report 9
Alessandro Invernizzi, Aniruddha Agarwal, Sapna Gangaputra, et al.
International Journal of Retina and Vitreous
|
March 25, 2021
Safety and efficacy of Razumab™ (world's first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study
Shashikant Sharma, Vishali Gupta, Aniruddha Maiti, et al.
Expert Opinion on Biological Therapy
|
May 8, 2026
Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III insight randomized clinical trial
Susan B Bressler, Piotr Oleksy, Daniel Virgil Alfaro, et al.
Ocular Immunology and Inflammation
|
September 18, 2023
Evaluating the Diagnostic Accuracy and Management Recommendations of ChatGPT in Uveitis
William Rojas-Carabali, Carlos Cifuentes-González, Xin Wei, et al.
Ocular Immunology and Inflammation
|
December 22, 2023
Response to the Comment on "Evaluating the Diagnostic Accuracy and Management Recommendations of ChatGpt in Uveitis"
William Rojas-Carabali, Carlos Cifuentes-González, Xin Wei, et al.
Page
of 45